KCS Wealth Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.73M | Sell |
40,974
-4,862
| -11% | -$442K | 1.59% | 12 |
|
|
2023
Q2 | $3.71M | Sell |
45,836
-720
| -2% | -$58.3K | 1.29% | 15 |
|
|
2023
Q1 | $3.7M | Sell |
46,556
-296
| -0.6% | -$23.6K | 1.4% | 11 |
|
|
2022
Q4 | $3.17M | Sell |
46,852
-6,870
| -13% | -$465K | 1.32% | 13 |
|
|
2022
Q3 | $2.68M | Sell |
53,722
-6,486
| -11% | -$323K | 1.23% | 16 |
|
|
2022
Q2 | $3.35M | Buy |
60,208
+968
| +2% | +$53.9K | 1.49% | 11 |
|
|
2022
Q1 | $3.29M | Buy |
59,240
+3,034
| +5% | +$168K | 1.52% | 13 |
|
|
2021
Q4 | $3.15M | Buy |
56,206
+1,250
| +2% | +$70K | 1.26% | 17 |
|
|
2021
Q3 | $2.64M | Buy |
54,956
+2,884
| +6% | +$138K | 1.25% | 19 |
|
|
2021
Q2 | $2.18M | Buy |
52,072
+9,594
| +23% | +$402K | 1.03% | 25 |
|
|
2021
Q1 | $1.43M | Buy |
42,478
+25,932
| +157% | +$874K | 0.74% | 43 |
|
|
2020
Q4 | $578K | Buy |
16,546
+10,586
| +178% | +$370K | 0.38% | 88 |
|
|
2020
Q3 | $207K | Sell |
5,960
-1,808
| -23% | -$62.8K | 0.17% | 135 |
|
|
2020
Q2 | $254K | Hold |
7,768
| – | – | 0.21% | 125 |
|
|
2020
Q1 | $234K | Sell |
7,768
-1,398
| -15% | -$42.1K | 0.24% | 117 |
|
|
2019
Q4 | $265K | Sell |
9,166
-766
| -8% | -$22.1K | 0.2% | 131 |
|
|
2019
Q3 | $257K | Sell |
9,932
-120
| -1% | -$3.1K | 0.18% | 133 |
|
|
2019
Q2 | $257K | Hold |
10,052
| – | – | 0.2% | 133 |
|
|
2019
Q1 | $263K | Sell |
10,052
-368
| -4% | -$9.63K | 0.23% | 125 |
|
|
2018
Q4 | $240K | Sell |
10,420
-1,482
| -12% | -$34.1K | 0.25% | 130 |
|
|
2018
Q3 | $281K | Sell |
11,902
-6,024
| -34% | -$142K | 0.26% | 126 |
|
|
2018
Q2 | $413K | Sell |
17,926
-4,626
| -21% | -$107K | 0.38% | 103 |
|
|
2018
Q1 | $555K | Sell |
22,552
-2,654
| -11% | -$65.3K | 0.5% | 84 |
|
|
2017
Q4 | $676K | Buy |
+25,206
| New | +$676K | 0.65% | 53 |
|